Gary DeWaal, Financial Markets and Funds special counsel, spoke with the Financial Times on challenges for US investors looking to trade certain derivatives tied to South Korea’s benchmark stock index. Changes to the Kopsi 200 have resulted in the index changing classifications, which subsequently shifts regulatory purview to the Securities and Exchange Commission (SEC) and CFTC. Gary noted that the KRX likely determined to suspend reliance on CME Group’s Globex platform for access to its security futures due to potential issues inherent to US regulation when a product "which was regulated one way on one day could be entirely differently regulated on a different day." ("Samsung shares create Korea headache for US investors," April 8, 2020)